Acknowledgments
Jennifer A., Cancer
ONCOLOGY, GYNECOLOGIC CANCER, CANCER
We remain indebted to the participating patients, their families, and the clinical trial investigators and research coordinators of the Dana-Farber/Harvard Cancer Center Gynecologic Cancers Program. We want to acknowledge the support of Sanofi in ensuring that these data are peer reviewed and published and Jennifer A. Smith, Sr., previously Director Biometrics BiPar Sciences and Sanofi, for help with access to and analysis of the data. Presented in part at the 2011 American Society of Clinical Oncology Annual Meeting.